Canada markets closed

Chimerix, Inc. (CMRX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
5.33-0.37 (-6.49%)
At close: 4:00PM EDT
5.33 0.00 (0.00%)
After hours: 07:15PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close5.70
Bid5.18 x 1400
Ask5.54 x 1100
Day's Range5.14 - 5.69
52 Week Range2.54 - 11.57
Avg. Volume675,751
Market Cap459.711M
Beta (5Y Monthly)1.64
PE Ratio (TTM)N/A
EPS (TTM)-1.90
Earnings DateNov. 03, 2021 - Nov. 08, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est17.67
  • GlobeNewswire

    Chimerix to Present at H.C. Wainwright 23rd Annual Global Investment Conference

    DURHAM, N.C., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases, today announced that Mike Sherman, Chief Executive Officer of Chimerix and Mike Andriole, Chief Financial and Business Officer of Chimerix, will participate in a pre-recorded fireside chat at the H.C. Wainwright 23rd Annual Global Investment Conference that will be made available on Monday, September

  • Motley Fool

    Chimerix (CMRX) Q2 2021 Earnings Call Transcript

    With me on today's call are president and chief executive officer, Mike Sherman; and chief financial and business officer, Mike Andriole. Allen Melemed, our chief medical officer; and Josh Allen, our chief technology officer of Imipridones, are here to participate in Q&A. Before we begin, I would like to remind you that statements made on today's call include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and are subject to risks and uncertainties, and other factors.

  • Simply Wall St.

    Did You Miss Chimerix's (NASDAQ:CMRX) Impressive 108% Share Price Gain?

    Chimerix, Inc. ( NASDAQ:CMRX ) shareholders might be concerned after seeing the share price drop 17% in the last...